What the MCCQE tests in hematology and oncology
The MCC Examination Objectives frame hematology and oncology around presentations a new family physician or resident must handle safely: anemia, bleeding, a low or high cell count, a lump or lymph node, a swollen leg, weight loss, and a patient with cancer who becomes acutely unwell. You are not expected to choose chemotherapy regimens. You are expected to recognise the pattern, order the right first test, act on emergencies, and know when to refer.
Questions spread across all four dimensions of care. Health promotion and illness prevention shows up as cancer screening and iron supplementation in pregnancy. Acute care shows up as febrile neutropenia, spinal cord compression and pulmonary embolism. Chronic care covers long-term anticoagulation, sickle cell disease and survivorship. Psychosocial care covers breaking bad news, goals-of-care conversations and palliation.
The physician activities matter as much as the facts. Many stems ask for the next diagnostic test (assessment and diagnosis), the safest immediate step (management), what to tell a patient who asks to stop screening or treatment (communication), or how to respond to a request for medical assistance in dying (professional behaviours). Read the lead-in first so you know which activity the item is testing.
- Lab values are in SI units: hemoglobin in g/L, platelets and neutrophils in x10^9/L, ferritin in micrograms/L.
- Expect two-step items: interpret a CBC or smear, then choose the action.
- Screening items test the Canadian Task Force, not US Preventive Services Task Force ages.
How the MCCQE frames hematology and oncology: three mini cases
Most items in this area are built from a common presentation and then push you toward one decision. The dimension of care tells you what kind of decision: an acute item wants the safe first action, a chronic item wants the right follow-up, a health promotion item wants the right screening or prevention step, and a psychosocial item wants a conversation. Reading the three short cases below the way the exam writer intended is good practice for the real thing.
Case one. A 34-year-old woman tells her family physician she is tired. Her hemoglobin is 92 g/L with an MCV of 72 fL, and she describes heavy periods with clots. The exam is testing whether you confirm iron deficiency with a ferritin, treat with oral iron, and deal with the cause by assessing the heavy menstrual bleeding. Endoscopy is not the first answer here, because a premenopausal woman with a clear source of loss is a different patient from a 60-year-old man. If she cannot tolerate oral iron or does not respond, IV iron is the next step, and transfusion is reserved for instability or severe symptoms.
Case two. A 72-year-old man has a routine CBC showing lymphocytes of 18 x10^9/L, a normal hemoglobin and platelet count, and smudge cells on the smear. He feels well and has no nodes or organomegaly. The exam wants flow cytometry of the peripheral blood to confirm chronic lymphocytic leukemia, then observation with regular CBCs. Treatment is triggered by symptoms, falling counts or bulky disease, not by the lymphocyte number alone. Choosing chemotherapy or a bone marrow biopsy as the next step is the trap.
Case three. A 45-year-old woman with a bleeding duodenal ulcer has a hemoglobin of 65 g/L. She is alert, capable, and tells you she is a Jehovah's Witness who does not accept blood. This is a professional behaviour item. The best answer respects a capable adult's informed refusal, confirms she understands the risk of death, documents the discussion, and maximises every acceptable alternative: endoscopic control of bleeding, IV iron, tranexamic acid where appropriate and minimising blood draws. Offer to involve the hospital liaison committee if she wishes. Overriding her refusal, or asking her family to persuade her, is wrong.
- Acute items: safe first action before confirmation.
- Chronic items: the right follow-up interval and trigger for treatment.
- Health promotion items: the Canadian screening or prevention answer.
- Psychosocial items: consent, refusal, bad news and goals of care.
Anemia, thrombocytopenia and bleeding: the decision points
Start every anemia question with the MCV and the reticulocyte count. A low MCV points to iron deficiency, thalassemia trait or, less often, anemia of chronic disease. Ferritin is the single most useful test: a low ferritin confirms iron deficiency. Because ferritin rises with inflammation, a normal value does not fully exclude iron deficiency in a patient with active inflammatory disease. Once iron deficiency is confirmed in a man or a postmenopausal woman, the exam wants you to look for gastrointestinal blood loss with endoscopy, not just prescribe iron.
Macrocytic anemia sends you to vitamin B12 and folate, alcohol use, liver disease, hypothyroidism, medications such as methotrexate, and myelodysplasia in older adults. A raised reticulocyte count with anemia means loss or destruction: check LDH, haptoglobin, indirect bilirubin, the peripheral smear and a direct antiglobulin test. Spherocytes with a positive direct antiglobulin test suggest warm autoimmune hemolysis; schistocytes suggest a microangiopathic process and should make you think of TTP, HUS or DIC.
For thrombocytopenia, first exclude pseudothrombocytopenia from EDTA clumping by repeating the count in a citrate tube. Isolated thrombocytopenia in a well patient with a normal smear is often immune thrombocytopenia, a diagnosis of exclusion. Thrombocytopenia plus microangiopathic hemolysis, with or without fever, renal injury or neurological change, is TTP until proven otherwise: urgent plasma exchange, and avoid platelet transfusion unless bleeding is life-threatening.
Heparin-induced thrombocytopenia is a favourite. The platelet count usually falls by more than half about 5 to 10 days after heparin starts, and the patient may develop new thrombosis. Use the 4Ts score, stop all heparin including flushes, start a non-heparin anticoagulant, and do not start warfarin until the platelet count has recovered. For bleeding disorders, a prolonged aPTT with a normal PT suggests hemophilia A or B or von Willebrand disease; von Willebrand disease is the most common inherited bleeding disorder and presents with mucosal bleeding and heavy menstrual bleeding.
- Microcytic anemia: ferritin first, then look for the source of loss.
- Hemolysis screen: reticulocytes, LDH, haptoglobin, indirect bilirubin, smear, direct antiglobulin test.
- TTP: plasma exchange now; do not wait for ADAMTS13 results.
- HIT: stop heparin, start argatroban or another non-heparin agent, no platelets, no early warfarin.
Anemia work-up in six decisions
- 1Is the patient stable?Bleeding with hypotension or chest pain needs resuscitation and the source controlled before any work-up.
- 2Read the MCVLow MCV: iron deficiency, thalassemia trait, chronic disease. High MCV: B12, folate, alcohol, liver, drugs, myelodysplasia.
- 3Check the reticulocyte countA high count means loss or destruction. A low count means the marrow is not keeping up.
- 4Low MCV: order ferritinLow ferritin confirms iron deficiency. Then find the source, with endoscopy in men and postmenopausal women.
- 5Hemolysis: LDH, haptoglobin, smear, DATSpherocytes with a positive DAT suggest autoimmune hemolysis; schistocytes suggest TTP, HUS or DIC.
- 6Treat the cause, not just the numberIron, B12 or folate as needed. Transfuse only for instability or severe symptoms, one unit at a time.
Reading coagulation tests and the peripheral smear
Many hematology items hand you a coagulation panel and ask what it means. Sort it by which test is prolonged. An isolated raised INR points to warfarin, early vitamin K deficiency or early liver disease, because factor VII has the shortest half-life and falls first. An isolated prolonged aPTT points to unfractionated heparin, a deficiency of factor VIII, IX or XI, von Willebrand disease when factor VIII is low, or a lupus anticoagulant. Both prolonged suggests DIC, advanced liver disease, severe vitamin K deficiency, massive transfusion or a large warfarin excess.
A mixing study separates deficiency from inhibitor. If mixing the patient's plasma with normal plasma corrects the aPTT, a factor is missing. If it does not correct, an inhibitor is present: a lupus anticoagulant, which causes clots rather than bleeding, or an acquired factor VIII inhibitor, which causes sudden large bruises and muscle bleeds in an older adult or a postpartum woman. That second picture is an urgent hematology referral.
Match the bleeding pattern to the defect. Mucocutaneous bleeding, such as nosebleeds, gum bleeding, easy bruising and heavy periods, suggests a platelet problem or von Willebrand disease, the most common inherited bleeding disorder. Deep bleeding into joints and muscles suggests a clotting factor deficiency such as hemophilia A or B, which are X-linked and seen mainly in males. DIC shows a falling platelet count, low fibrinogen, raised D-dimer and schistocytes in a patient with sepsis, trauma, obstetric catastrophe or acute promyelocytic leukemia; treat the cause and support with products only for bleeding or procedures. In liver disease, factor VIII is usually normal or raised, which helps separate it from DIC.
The smear description is often the single deciding clue, so learn the short list. Auer rods mean acute myeloid leukemia. Hypersegmented neutrophils mean B12 or folate deficiency. Target cells suggest thalassemia or liver disease. Teardrop cells suggest marrow infiltration or fibrosis. Bite cells after an oxidant drug or fava beans suggest G6PD deficiency. Rouleaux suggests myeloma. Spherocytes suggest hereditary spherocytosis or warm autoimmune hemolysis, and the direct antiglobulin test separates them.
- Isolated INR rise: warfarin, vitamin K deficiency, early liver disease.
- Isolated aPTT rise: heparin, hemophilia, von Willebrand disease, lupus anticoagulant.
- Mixing study corrects: deficiency. Does not correct: inhibitor.
- Mucocutaneous bleeding: platelets or von Willebrand. Joint bleeding: factor deficiency.
Venous thromboembolism: diagnosis, treatment and duration
VTE questions test a fixed sequence. Estimate pre-test probability with the Wells score. If DVT or PE is unlikely, a negative D-dimer rules it out; many Canadian centres use an age-adjusted D-dimer cut-off for patients older than 50. If the clinical probability is high, go straight to imaging: compression ultrasound for DVT, CT pulmonary angiography for PE, or a ventilation-perfusion scan when contrast is a problem. In a low-risk emergency patient, the PERC rule can remove the need for a D-dimer at all.
For most patients without cancer, a direct oral anticoagulant such as apixaban or rivaroxaban is first-line, as Thrombosis Canada guidance supports. For cancer-associated thrombosis, a DOAC or low-molecular-weight heparin is reasonable, weighing bleeding risk, especially with gastrointestinal or genitourinary tumours. In pregnancy, use low-molecular-weight heparin: warfarin and DOACs are avoided. In severe renal impairment or with mechanical heart valves, warfarin or heparin is preferred over a DOAC.
Duration is where the exam separates candidates. A VTE provoked by a major transient risk factor such as surgery is treated for about 3 months and then stopped. An unprovoked VTE carries a high recurrence risk, so extended anticoagulation is offered if bleeding risk is acceptable, with periodic review. For women with a first unprovoked VTE, the HERDOO2 rule, developed in Canada, identifies a low-risk group in whom stopping can be considered; it does not apply to men. Massive PE with hypotension calls for thrombolysis if there is no contraindication.
- Unlikely probability: D-dimer first. Likely probability: image first.
- Pregnancy: low-molecular-weight heparin throughout.
- Provoked by surgery: about 3 months. Unprovoked: consider indefinite therapy with yearly review.
Transfusion, transfusion reactions and anticoagulant reversal
Canadian practice is restrictive about red cells, and Choosing Wisely Canada has made this a national message. For most stable, non-bleeding inpatients, a hemoglobin threshold of about 70 g/L is used, with a somewhat higher threshold considered in patients with active cardiac ischemia. Give one unit at a time and reassess the patient and the hemoglobin before giving another. A stable patient with iron deficiency anemia needs iron, not blood. Exam options that transfuse a well patient to reach a round number are usually wrong.
Transfusion reactions are tested by timing and vital signs. Fever, chills, flank pain, hypotension and dark urine early in a transfusion suggest an acute hemolytic reaction, usually from an ABO identification error: stop the transfusion, keep the line open with saline, recheck the patient's identity against the unit and notify the blood bank. Isolated hives can be managed by pausing, giving an antihistamine and resuming if symptoms settle. Anaphylaxis needs IM epinephrine and the transfusion is stopped. New hypoxia within about 6 hours of a transfusion with bilateral infiltrates and no fluid overload suggests transfusion-related acute lung injury, which needs respiratory support. Dyspnea with hypertension, raised JVP and crackles, especially in an older patient with heart or kidney disease, suggests transfusion-associated circulatory overload, which responds to stopping the transfusion, sitting the patient up, oxygen and a diuretic.
Anticoagulant reversal follows the bleed. A patient on warfarin with a major or life-threatening bleed, such as an intracranial hemorrhage, needs warfarin stopped, IV vitamin K and prothrombin complex concentrate. Plasma is slower, needs a large volume and is not the preferred reversal agent in Canadian practice when prothrombin complex concentrate is available. A raised INR without bleeding is managed by holding doses, with a small oral dose of vitamin K if the INR is very high. Dabigatran has a specific reversal agent, idarucizumab. For life-threatening bleeding on apixaban or rivaroxaban, follow the local protocol, which in many Canadian hospitals uses prothrombin complex concentrate. In every case, the exam also expects you to find and control the source of bleeding.
Blood products need informed consent like any other treatment, including a discussion of risks, benefits and alternatives. A capable adult may refuse. For a child whose parents refuse a needed transfusion, the approach in an emergency is to give the treatment that is necessary to prevent death or serious harm, follow hospital policy and provincial law, and involve child protection services; in a non-urgent situation there is time for discussion, ethics consultation and legal advice.
- Stable inpatient: threshold about 70 g/L, one unit at a time.
- Hemolytic reaction: stop, check identity, call the blood bank.
- Overload (TACO): hypertension, raised JVP, crackles; give a diuretic.
- Major bleed on warfarin: IV vitamin K plus prothrombin complex concentrate.
Lymphadenopathy, leukemia, lymphoma and myeloma
A lymph node raises concern when it is larger than about 1 cm, hard, fixed, persists beyond 4 to 6 weeks, sits in the supraclavicular fossa, or comes with fever, night sweats or weight loss. If lymphoma is suspected, the next step is an excisional biopsy. A fine needle aspirate does not show node architecture, and lymphoma classification depends on it. A localised tender node with an obvious infection can be observed.
In leukemia, the CBC tells the story. Very high white counts with blasts in an unwell adult suggest acute myeloid leukemia; promyelocytes and DIC suggest acute promyelocytic leukemia, which is an emergency where all-trans retinoic acid is started as soon as the diagnosis is suspected. A child with bone pain, pallor, bruising and blasts suggests acute lymphoblastic leukemia. An older adult with an incidental lymphocytosis and smudge cells usually has chronic lymphocytic leukemia, and many patients are observed rather than treated. A raised white count with basophilia and splenomegaly suggests chronic myeloid leukemia, confirmed by BCR-ABL testing.
Multiple myeloma appears as the older patient with back pain, anemia, raised creatinine and a high calcium, often with a total protein far above albumin. Order serum protein electrophoresis with immunofixation, serum free light chains and urine studies, plus skeletal imaging with low-dose whole-body CT or a skeletal survey. Alkaline phosphatase is often normal because lytic lesions lack osteoblastic activity, so a bone scan can miss them. Avoid NSAIDs and unnecessary IV contrast to protect the kidneys.
- Suspected lymphoma: excisional node biopsy, not fine needle aspirate.
- Suspected APL: start all-trans retinoic acid and treat DIC before confirmation returns.
- Myeloma: CRAB features (calcium, renal, anemia, bone).
Oncologic emergencies and palliative care
Febrile neutropenia is the oncologic emergency the MCCQE asks most. A patient on chemotherapy with fever and a neutrophil count below 0.5 x10^9/L, or expected to fall below it, needs blood cultures and IV broad-spectrum antipseudomonal antibiotics, such as piperacillin-tazobactam, within the first hour. Do not wait for cultures or imaging. Low-risk patients may later step down to oral therapy, but an unstable patient is never sent home.
Malignant spinal cord compression presents as new back pain in a patient with cancer, worse lying down, then weakness, sensory level or sphincter change. Give dexamethasone and get an urgent MRI of the whole spine, then arrange radiation or surgery. Hypercalcemia of malignancy is treated with IV normal saline first, then an IV bisphosphonate. Tumour lysis syndrome follows treatment of bulky or fast-growing tumours and gives high potassium, phosphate and uric acid with low calcium: prevention with hydration and allopurinol, or rasburicase in high-risk patients, is the key point. Superior vena cava obstruction in a stable patient needs a tissue diagnosis before steroids, which can obscure lymphoma.
Palliative care questions test comfort and communication. Treat cancer pain with regular opioids plus a breakthrough dose, and prescribe a laxative from the first dose because opioid constipation does not improve with time. In renal impairment, hydromorphone is usually preferred to morphine because morphine metabolites accumulate. Nausea, dyspnea and delirium at the end of life each have a cause-based approach. Medical assistance in dying is legal in Canada for eligible adults under the Criminal Code; the exam tests that you respond respectfully, explore the request, and follow your provincial college rules on referral or transfer of care if you have a conscientious objection.
- Febrile neutropenia: cultures and antibiotics in the first hour.
- Cord compression: dexamethasone, then urgent whole-spine MRI.
- Hypercalcemia: saline first, bisphosphonate second.
- Every opioid prescription comes with a bowel regimen.
Cancer screening: Canadian practice and how it differs from US practice
Screening items are the clearest place where a US-based review book will lead you to the wrong answer. The Canadian Task Force on Preventive Health Care sets the national recommendations, and provincial programs deliver them, so the exam answer follows the Task Force unless the stem gives provincial context. Know the principle behind each recommendation: screening is offered where benefit outweighs harm for average-risk people, and higher-risk people follow a different pathway.
Colorectal cancer screening for average-risk adults is recommended from age 50 to 74, with a fecal immunochemical test every 2 years or flexible sigmoidoscopy every 10 years; the Task Force recommends against colonoscopy as the primary screening test for average-risk adults. US guidance starts at 45 and accepts colonoscopy as a first-line option. A first-degree relative with colorectal cancer moves the patient to colonoscopy-based surveillance.
For prostate cancer, the Task Force recommends against PSA screening, which differs from the US shared decision-making approach for men aged 55 to 69. For breast cancer, the Task Force has recommended mammography for average-risk women from 50 to 74 every 2 to 3 years, while several provinces now let women book from age 40; when a stem names the province, follow the provincial program, and either way a woman in her forties who asks should be informed of benefits and harms. Lung cancer screening with low-dose CT is for adults aged 55 to 74 with a heavy smoking history who smoke now or quit recently. Cervical screening is moving from cytology to HPV testing across provinces, so learn the principle: start at about age 25 and stop around 65 to 70 after adequate negative results.
- Colorectal, average risk: FIT every 2 years, ages 50-74.
- Prostate: no routine PSA screening.
- Lung: low-dose CT only for heavy smokers aged 55-74.
- Never screen a patient with symptoms: investigate instead.
Cancer screening: Canadian answer vs US habit
Canadian Task Force or provincial program
- Colorectal: FIT every 2 years from 50 to 74 for average risk
- Colonoscopy not recommended as the primary average-risk screen
- Prostate: no routine PSA screening
- Lung: low-dose CT for heavy smokers aged 55 to 74
- Cervical: provincial programs start at about 25, moving to HPV testing
Common US-based habit
- Colorectal screening starting at 45
- Colonoscopy every 10 years offered as a first-line option
- Shared decision on PSA for men aged 55 to 69
- Lung screening from 50 to 80 with a lower pack-year threshold
- Cervical screening starting at 21
How to read hematology and oncology stems
Look at the timeline first. A platelet fall 5 to 10 days after starting heparin is HIT; a fall on day 1 is not. Fever 7 to 14 days after chemotherapy is neutropenic until proven otherwise. A swollen leg within weeks of surgery is provoked VTE. Then check the values: hemoglobin in g/L, a neutrophil count, calcium, creatinine and the smear description are usually the deciding clues.
Next decide whether the patient is stable. An unstable patient gets the emergency step, such as antibiotics, plasma exchange, steroids for cord compression or thrombolysis for massive PE, before any confirmatory test. A stable patient gets the most specific first test. Finally, ask whether the item is really a communication question in disguise: a patient asking to stop screening, refusing a transfusion as a Jehovah's Witness, or requesting assisted death needs a respectful conversation and documentation, not a lecture.
- Red flags: fever on chemotherapy, back pain with cancer, schistocytes, new thrombosis on heparin.
- Smear clues: schistocytes, spherocytes, smudge cells, Auer rods, hypersegmented neutrophils.
- If the patient is symptomatic, the answer is diagnosis, never screening.
How hematology and oncology show up in NAC stations
If you are also preparing for the NAC Examination, the same knowledge appears in a different form. A fatigue or anemia station tests a focused history: menstrual loss, gastrointestinal bleeding, melena, diet, NSAID and anticoagulant use, weight loss, family history of bleeding disorders and symptoms of malignancy. A swollen leg station asks for a focused history of VTE risk factors, a narrated leg exam and then a clear plan using a pre-test probability approach. A neck lump or lymph node station tests the B symptoms, a narrated exam of each node group, liver and spleen, and an honest plan for biopsy.
Communication stations in this area are common. Breaking news of a new cancer diagnosis tests whether you set up a private space, find out what the patient already knows, ask how much they want to know, give the news in plain words, pause for emotion and agree on next steps. Counselling a patient starting a DOAC tests adherence, signs of bleeding, interactions, what to do before procedures and when to seek care. At the 8-minute signal, oral questions often ask you to interpret a CBC, choose the next test or name the emergency you are worried about.
- Anemia history: bleeding source, diet, drugs, B symptoms, family history.
- Bad news: setting, perception, invitation, knowledge, emotion, plan.
- DOAC counselling: adherence, bleeding signs, interactions, procedures.
A one-week revision plan for this subject
If you have a week before your exam and this subject is weak, follow the plan in the timeline below. Each day pairs one block of reading with a timed set of questions from this question bank, and the last day is for mixed review only. Keep a single page of the mistakes you made and reread it every morning. The goal is not to memorise every disease but to make the first decision in each common presentation automatic.
One-week hematology and oncology revision
- Day 1Anemia and the smearSort anemia by MCV and reticulocytes, learn the smear clues, then do a timed set of anemia questions.
- Day 2Platelets and coagulationITP, TTP, HIT, DIC, von Willebrand disease, hemophilia and the mixing study.
- Day 3VTEWells score, D-dimer, imaging choice, DOAC versus heparin, duration and special populations.
- Day 4Transfusion and reversalThresholds, reactions by timing and vital signs, warfarin and DOAC reversal, consent and refusal.
- Day 5Leukemia, lymphoma, myelomaFirst test for each, when to observe, and which findings are emergencies.
- Day 6Emergencies, palliation, screeningThe emergency table, opioid and bowel regimens, and every Canadian screening statement.
- Day 7Mixed reviewA full mixed block, then reread your page of errors and redo every question you missed.
| Condition | Key clue in the stem | First action | Why the exam wants it |
|---|---|---|---|
| Febrile neutropenia | Fever after chemotherapy, neutrophils below 0.5 x10^9/L | Blood cultures and IV piperacillin-tazobactam within 1 hour | Delay to antibiotics increases mortality |
| Spinal cord compression | Back pain worse lying down, leg weakness, known cancer | Dexamethasone and urgent whole-spine MRI | Function at diagnosis predicts walking after treatment |
| TTP | Thrombocytopenia, schistocytes, raised LDH, confusion | Urgent plasma exchange | Platelet transfusion can worsen thrombosis |
| HIT | Platelets halve 5-10 days after heparin, new clot | Stop all heparin, start a non-heparin anticoagulant | Warfarin alone can cause limb gangrene |
| Tumour lysis syndrome | After treating a bulky lymphoma or leukemia | Aggressive IV fluids, allopurinol or rasburicase | Hyperkalemia and acute kidney injury kill quickly |
| Hypercalcemia of malignancy | Confusion, polyuria, constipation, high calcium | IV normal saline, then IV bisphosphonate | Patients are volume depleted |
| Acute promyelocytic leukemia | Blasts, bleeding, DIC picture | Start all-trans retinoic acid and correct coagulopathy | Early death is from bleeding |
| Massive pulmonary embolism | Hypotension, right heart strain, confirmed or likely PE | Systemic thrombolysis if no contraindication | Anticoagulation alone acts too slowly |
Worked examples in MCCQE style
Pick an answer to see why each option is right or wrong. These examples are written for this page; the bank holds the full set for hematology & oncology.
Example 1
A 58-year-old woman with breast cancer presents to the emergency department 10 days after her second cycle of chemotherapy. She has had chills since this morning. Temperature is 38.6 C, heart rate 112 beats/min, blood pressure 104/66 mmHg and oxygen saturation 96% on room air. Chest examination is normal and her port site is clean. Hemoglobin is 102 g/L, white blood cells 0.9 x10^9/L, neutrophils 0.3 x10^9/L and platelets 88 x10^9/L.
What is the most appropriate next step?
-
Waiting for cultures delays treatment in a condition where each hour of delay worsens outcome.
-
Oral outpatient therapy is only for carefully selected low-risk patients; she is tachycardic and borderline hypotensive.
-
Correct. Febrile neutropenia needs cultures and empirical antipseudomonal IV antibiotics within the first hour.
-
Growth factor does not treat the infection and is not a substitute for antibiotics.
-
Imaging may follow, but it must not delay antibiotics in a neutropenic patient with fever.
Show answer and reasoning
Answer: C. Draw blood cultures and start IV piperacillin-tazobactam now
- A. Waiting for cultures delays treatment in a condition where each hour of delay worsens outcome.
- B. Oral outpatient therapy is only for carefully selected low-risk patients; she is tachycardic and borderline hypotensive.
- C. Correct. Febrile neutropenia needs cultures and empirical antipseudomonal IV antibiotics within the first hour.
- D. Growth factor does not treat the infection and is not a substitute for antibiotics.
- E. Imaging may follow, but it must not delay antibiotics in a neutropenic patient with fever.
Fever plus neutropenia after chemotherapy: cultures, then IV antipseudomonal antibiotics within an hour.
Based on: Febrile neutropenia principles used by Canadian cancer centres; MCC Examination Objectives
Example 2
A 70-year-old woman is on day 6 after surgical repair of a hip fracture. She has received subcutaneous unfractionated heparin for prophylaxis since admission. Her platelet count was 240 x10^9/L before surgery and is 95 x10^9/L today. Her left calf is now swollen and tender, and compression ultrasound shows a popliteal vein thrombosis. She has no bleeding.
What is the most appropriate next step?
-
Low-molecular-weight heparin cross-reacts with HIT antibodies and must not be used.
-
Correct. Suspected HIT with thrombosis needs all heparin stopped and a non-heparin anticoagulant started.
-
Platelet transfusion is avoided in HIT without serious bleeding because it can fuel thrombosis.
-
Starting warfarin before platelet recovery can cause venous limb gangrene.
-
Continuing heparin with a high 4Ts score and a new clot exposes her to further thrombosis.
Show answer and reasoning
Answer: B. Stop heparin and start argatroban
- A. Low-molecular-weight heparin cross-reacts with HIT antibodies and must not be used.
- B. Correct. Suspected HIT with thrombosis needs all heparin stopped and a non-heparin anticoagulant started.
- C. Platelet transfusion is avoided in HIT without serious bleeding because it can fuel thrombosis.
- D. Starting warfarin before platelet recovery can cause venous limb gangrene.
- E. Continuing heparin with a high 4Ts score and a new clot exposes her to further thrombosis.
In HIT, stop every source of heparin and start a non-heparin anticoagulant; warfarin waits until platelets recover.
Based on: Thrombosis Canada clinical guide on heparin-induced thrombocytopenia
Example 3
A 52-year-old man has completed 3 months of apixaban for a pulmonary embolism. There was no surgery, immobilisation, cancer or other trigger, and an age-appropriate cancer screen is up to date and normal. He has had no bleeding, his kidney function is normal and he takes no other medications. He asks whether he can now stop the anticoagulant.
What is the most appropriate recommendation?
-
Three months is the standard for provoked VTE; an unprovoked event has a high recurrence risk after stopping.
-
ASA gives much less protection against recurrent VTE than continued anticoagulation.
-
Repeat imaging does not predict recurrence and is not a reason to stop treatment.
-
Correct. A first unprovoked PE with low bleeding risk warrants extended anticoagulation with periodic review.
-
D-dimer-based rules such as HERDOO2 apply to women; men with unprovoked VTE are advised to continue.
Show answer and reasoning
Answer: D. Continue apixaban long term, review yearly
- A. Three months is the standard for provoked VTE; an unprovoked event has a high recurrence risk after stopping.
- B. ASA gives much less protection against recurrent VTE than continued anticoagulation.
- C. Repeat imaging does not predict recurrence and is not a reason to stop treatment.
- D. Correct. A first unprovoked PE with low bleeding risk warrants extended anticoagulation with periodic review.
- E. D-dimer-based rules such as HERDOO2 apply to women; men with unprovoked VTE are advised to continue.
Unprovoked VTE with acceptable bleeding risk: offer indefinite anticoagulation and review it every year.
Based on: Thrombosis Canada VTE treatment and duration guidance
Example 4
A 78-year-old man taking warfarin for atrial fibrillation is brought to the emergency department after a fall at home. He has a headache and has vomited twice. His Glasgow Coma Scale score is 14. CT of the head shows an acute subdural hematoma. His INR is 3.4, hemoglobin 131 g/L and platelet count 210 x10^9/L. Neurosurgery has been called.
Which treatment should be given now to reverse his anticoagulation?
-
Correct. A life-threatening bleed on warfarin needs rapid reversal with prothrombin complex concentrate, plus IV vitamin K to sustain it.
-
Plasma is slower, needs a large volume and risks overload; it is not preferred when prothrombin complex concentrate is available.
-
Holding warfarin alone is right for a raised INR without bleeding, not for an intracranial hemorrhage.
-
Oral vitamin K acts too slowly here, and restarting warfarin tomorrow ignores the active bleed.
-
His platelet count is normal, and tranexamic acid does not reverse warfarin.
Show answer and reasoning
Answer: A. IV vitamin K plus prothrombin complex concentrate
- A. Correct. A life-threatening bleed on warfarin needs rapid reversal with prothrombin complex concentrate, plus IV vitamin K to sustain it.
- B. Plasma is slower, needs a large volume and risks overload; it is not preferred when prothrombin complex concentrate is available.
- C. Holding warfarin alone is right for a raised INR without bleeding, not for an intracranial hemorrhage.
- D. Oral vitamin K acts too slowly here, and restarting warfarin tomorrow ignores the active bleed.
- E. His platelet count is normal, and tranexamic acid does not reverse warfarin.
Major bleeding on warfarin: stop it, give IV vitamin K and prothrombin complex concentrate, and control the source.
Based on: Thrombosis Canada clinical guide on warfarin and management of bleeding
Example 5
An 81-year-old woman with heart failure and chronic kidney disease is admitted with pneumonia. Her hemoglobin is 68 g/L and she is not bleeding. Two units of red cells were ordered together. Ninety minutes into the second unit she becomes short of breath. Blood pressure is 176/94 mm Hg, heart rate 108/min, temperature 37.1 C and oxygen saturation 87% on room air. She has a raised JVP and bilateral crackles.
What is the most appropriate next step?
-
An antihistamine treats isolated hives, not hypoxia with signs of fluid overload.
-
She is afebrile and the picture is overload, not transfusion-transmitted sepsis.
-
Epinephrine is for anaphylaxis, which causes hypotension, not hypertension with a raised JVP.
-
Continuing the transfusion adds more volume to a patient who is already overloaded.
-
Correct. Hypertension, raised JVP and crackles during transfusion suggest circulatory overload: stop, sit up, oxygen and a diuretic.
Show answer and reasoning
Answer: E. Stop the transfusion and give IV furosemide
- A. An antihistamine treats isolated hives, not hypoxia with signs of fluid overload.
- B. She is afebrile and the picture is overload, not transfusion-transmitted sepsis.
- C. Epinephrine is for anaphylaxis, which causes hypotension, not hypertension with a raised JVP.
- D. Continuing the transfusion adds more volume to a patient who is already overloaded.
- E. Correct. Hypertension, raised JVP and crackles during transfusion suggest circulatory overload: stop, sit up, oxygen and a diuretic.
Transfusion-associated circulatory overload looks like heart failure; in a stable patient at risk, give one unit at a time and reassess.
Based on: Canadian Blood Services clinical guide to transfusion; Choosing Wisely Canada transfusion medicine recommendations
Quick recall
Tap a card to turn it over. If you can answer all of them without looking, move on to timed questions.
Where candidates lose marks
- Platelets in TTP or HIT
Transfusing platelets in TTP or HIT without life-threatening bleeding can worsen thrombosis. The answer is the disease-specific treatment.
- US screening ages
Starting colorectal screening at 45 or offering routine PSA screening follows US practice, not the Canadian Task Force.
- Iron without investigation
Treating iron deficiency in an older adult without looking for a GI source misses colorectal cancer.
- FNA for a suspicious node
A fine needle aspirate cannot classify lymphoma. Choose excisional biopsy.
- Waiting in febrile neutropenia
Any option that delays antibiotics for imaging, cultures or a repeat CBC is wrong in a febrile neutropenic patient.
How to study hematology & oncology
Learn the anemia algorithm by MCV and reticulocyte count until you can sort a CBC in under a minute.
Memorise the oncologic emergency table: clue, first action and reason for each row.
Read the Thrombosis Canada summaries on VTE diagnosis, treatment duration and HIT.
Review each Canadian Task Force cancer screening statement and note where it differs from US guidance.
Do 150-200 hematology and oncology questions in this question bank in timed blocks, and write one line on every miss.
Finish with palliative care and goals-of-care communication items, which often appear in mixed blocks.
Sources and further reading
Check the current edition of each guideline before your exam. This page is study material, not clinical advice.